0
0
2/17/23 at 12:55pm
Organization
Forbes
Author
Arianna Johnson
36 words
0
Comments
Most people are expected to contract RSV by the age of two, though no vaccine has yet to be approved.
You are the first to view
https://www.forbes.com/sites/ariannajohnson/2023/02/17/first-fda-approved-rsv-vaccines-expected-later-this-year-the-top-vaccines-and-their-effectiveness/
Create an account
or login to join the discussion